According to a study on non-small cell lung cancer patients receiving Gefitinib therapy, the circular RNA hsa_circ_0109320 showed significantly elevated expression levels in individuals who positively responded to EGFR-TKI treatment [205]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.